Shuttle Pharmaceuticals ...

NASDAQ: SHPH · Real-Time Price · USD
3.34
-0.16 (-4.57%)
At close: Aug 15, 2025, 3:59 PM
3.35
0.30%
After-hours: Aug 15, 2025, 06:30 PM EDT

Shuttle Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
5.75K 5.75K 5.75K 9.66K 9.66K 9.66K 9.66K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
4.67K 5.64K 6.54K 5.65K 6.71K 7.24K 6.81K 22.16K 20.31K 18.82K 33.38K 32.42K 32.42K 32.42K 35.29K 18.91K 18.91K 18.91K
Gross Profit
-3.6K -4.56K -5.46K 4.01K 2.94K 2.42K 2.85K -22.16K -20.31K -18.82K -33.38K -32.42K -32.42K -32.42K -35.29K -18.91K -18.91K -18.91K
Operating Income
-11.69M -9.26M -7.7M -7.2M -5.75M -5.73M -5.89M -5.35M -4.57M -3.46M -2.55M -2.8M -2.22M -2.21M -1.74M -754.45K -512.34K -176.09K
Interest Income
2.61K 16.68K 38.14K 60.53K 78.77K 83.88K 79.12K 56.72K 35.95K 16.69K n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
-12.14M -10.47M -9.14M -9.19M -7.2M -7.35M -6.59M -5.7M -4.91M -3.32M -3.03M -2.74M -1.96M -1.7M -1.15M -693.09K -476.13K -129.32K
Net Income
-12.14M -10.47M -9.14M -9.19M -7.2M -7.35M -5.33M -4.51M -3.74M -2.4M -3.41M -3.04M -2.24M -1.75M -1.15M -693.09K -476.13K -129.32K
Selling & General & Admin
4.06M 2.55M 2.75M 2.81M 2.94M 2.64M 2.37M 1.83M 1.52M 1.26M 1.07M 1.31M 1.21M 993.58K 721.18K 174.77K 119.61K 70.09K
Research & Development
4.99M 4.61M 3.62M 3.06M 2.8M 3.09M 3.52M 3.52M 3.05M 2.2M 1.49M 1.49M 1.01M 1.21M 1.02M 579.68K 392.73K 106K
Other Expenses
2.64M 2.1M 1.32M 1.32M n/a n/a n/a 866.77K 866.77K 866.77K 866.77K n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
11.69M 9.26M 7.69M 7.2M 5.75M 5.73M 5.89M 5.35M 4.57M 3.46M 2.55M 2.8M 2.22M 2.21M 1.74M 754.45K 512.34K 176.09K
Interest Expense
465.63K 874.57K 1.36M 1.73M 2.08M 2.38M 2.49M 1.97M 1.96M 1.42M 969.89K 978.45K 370.67K 196.11K 50.79K 32.1K 21.44K 10.78K
Selling & Marketing Expenses
n/a 525.91K 525.91K 523.93K 523.93K -1.98K -1.98K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
8.14M 5.71M 4.14M 7.2M 5.75M 5.73M 5.89M 5.35M 4.57M 3.46M 2.55M 2.8M 2.22M 2.21M 1.74M 754.45K 512.34K 176.09K
Income Tax Expense
n/a n/a n/a -3 -3 -3 -1.26M -1.19M -1.19M -946.15K 358.1K 287.09K 287.09K 43.44K n/a n/a n/a n/a
Shares Outstanding (Basic)
1.13M 4.08M 4.08M 10.32M 10.32M 16.57M 16.07M 15.74M 14.26M 13.64M 13.6M 10.16M 13.28M 13.28M 13.59M 13.28M 13.28M 13.28M
Shares Outstanding (Diluted)
1.13M 4.08M 4.08M 10.32M 10.32M 16.57M 16.07M 15.74M 14.26M 13.64M 13.6M 10.16M 13.28M 13.28M 13.59M 13.28M 13.28M 13.28M
EPS (Basic)
-4.95 -1.86 -1.21 -0.77 -0.51 -0.46 -0.34 -0.3 -0.29 -0.2 -0.28 -0.25 -0.17 -0.13 -0.09 -0.05 -0.04 -0.01
EPS (Diluted)
-4.96 -1.87 -1.22 -0.77 -0.51 -0.46 -0.34 -0.3 -0.29 -0.2 -0.28 -0.25 -0.17 -0.13 -0.09 -0.05 -0.04 -0.01
EBITDA
-11.81M -9.5M -7.78M -7.45M -5.11M -4.96M -4.09M -3.71M -2.92M -1.89M -2.03M -1.73M -1.55M -1.47M -1.06M -631.82K -425.52K -99.63K
EBIT
-11.68M -9.59M -7.78M -7.45M -5.11M -4.96M -4.1M -3.73M -2.94M -1.9M -2.06M -1.76M -1.58M -1.51M -1.1M -660.98K -454.68K -118.55K
Depreciation & Amortization
3.6K 4.56K 5.46K 5.65K 6.71K 7.24K 6.81K 22.16K 21.89K 21.86K 36.42K 35.46K 49.05K 57.97K 60.83K 44.46K 29.28K 18.91K